News

Fully implantable hearing device debuts at the General Hospital Vienna (AKH)

Vienna, 13 March 2008 – A 51-year-old woman from Vienna has become the first person in Austria to receive a fully...

Antibody Engineering Company F-Star Opens Second Research Site in Cambridge, UK

Antibody Engineering Company F-Star Opens Second Research Site in Camebridge, UK

LISAvienna News

New: LISA VR event calender

Since March 2008 LISA VR's event calender is online.

Focus: Networking events, conferences, symposia, workshops,...

CCRI coordinates new FP7 funded project - DIRECT

The Children's Cancer Research Institute, the German Childhood Cancer Foundation, the St. Anna Children's Hospital and...

Winning projects in the Best of Biotech competition announced

Winning projects in the Best of Biotech competition announced

>> Life sciences business ideas off to a flying start

BOKU: New Christian Doppler Pilot Lab for rapid test systems for allergenic food contaminants

At Technopole Tulln the University of Natural Ressources and Applied Life Sciences opened a new Christian Doppler Pilot...

Intercell announces Q4 and preliminary full year 2007 results

Intercell announces Q4 and preliminary full year 2007 results First profitable year in company history – Vaccine against...

Intercell: Licensure application for Japanese Encephalitis vaccine submitted to Therapeutic Goods Administr...

Intercell: Licensure application for Japanese Encephalitis vaccine submitted to Therapeutic Goods Administration (TGA)...

Intercell completes Phase I clinical trial for an improved seasonal Influenza vaccine formulated with IC31(R)

Intercell completes Phase I clinical trial for an improved seasonal Influenza vaccine formulated with IC31(R)

»...

Marinomed Biotechnologie GmbH presents its first product - Carragelose(R) in the nasal spray COLDAMARIS pro...

Marinomed Biotechnologie GmbH presents its first product - Carragelose(R) in the nasal spray COLDAMARIS prophylactic

Affiris expands patent portfolio for Alzheimer's therapies

Affiris GmbH has secured another Europe-wide patent for an innovative method of treating Alzheimer's disease. This new...

Sanochemia: Withdrawal from planned investment in Countervail

Sanochemia: Withdrawal from planned investment in Countervail

>> Return of USD 560,000 planned as a deposit

>>...